|
| Status |
Public on Dec 31, 2008 |
| Title |
Oligonucleotide array CGH in high-risk neuroblastoma tumors |
| Organism |
Homo sapiens |
| Experiment type |
Genome variation profiling by array
|
| Summary |
We performed array CGH in high-risk neuroblastoma tumors in order to compare genome aberrations with expression of small non-coding RNAs.
|
| |
|
| Overall design |
We analyzed 33 NB primary tumors collected at the onset of disease. All patients were classified as stage 4 according to the International Neuroblastoma Staging System (Brodeur GM, Pritchard J, Berthold F, et al. Revision of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol. 1993; 11: 1466-1477) and they were older than 1 year of age at time of diagnosis. Regarding clinical course, patients were categorized into two subgroups: “good-outcome” (n = 16, neither relapse nor progression), and “poor-outcome” (n = 17, died due to the disease).
|
| |
|
| Contributor(s) |
Scaruffi P, Stigliani S, Coco S, De Vecchi C, Valdora F, Tonini G |
| Citation(s) |
20003513 |
| Submission date |
Dec 23, 2008 |
| Last update date |
Dec 06, 2012 |
| Contact name |
PAOLA SCARUFFI |
| E-mail(s) |
paola.scaruffi@hsanmartino.it
|
| Organization name |
"San Martino" Hospital
|
| Lab |
Center of Physiopathology of Human Reproduction
|
| Street address |
LARGO R. BENZI, 10
|
| City |
Genova |
| State/province |
GE |
| ZIP/Postal code |
16132 |
| Country |
Italy |
| |
|
| Platforms (2) |
| GPL2873 |
Agilent-012750 Human Genome CGH Microarray 44A (Feature number version) |
| GPL5477 |
Agilent-014950 Human Genome CGH Microarray 4x44K (Feature Number version) |
|
| Samples (33)
|
|
| Relations |
| BioProject |
PRJNA111201 |
Less...
More...